The influence of symbiotics in multi-organ failure: Randomised trial

作者：de Toro Martin Consuegra Ismael Lopez; Sanchez Casado Marcelino^*; Jose Perez Pedrero Sanchez Belmonte M; Lopez Reina Torrijos Pilar; Raigal Cano Ana; Heredero Galvez Eva; Brea Zubigaray Susana; Angeles Arrese Cosculluela M

来源：Medicina Clinica, 2014, 143(4): 143-149.

DOI：10.1016/j.medcli.2013.09.046

• Multi-organ failure
• Simbiotics
• Probiotics
• Trial
• Intensive Care Unit

Background and objective: To assess whether the administration of symbiotic preparations in patients with multi-organ failure (MOF) diminishes the evolution of the failure, the inflammatory response generated, the colonization pattern and the Intensive Care Unit (ICU) infectious illness.
Patients and method: Randomized and controlled trial. All patients with MOF were included. Neutropenia and acute pancreatitis patients were excluded. A symbiotic (Simbiotic Drinko (R)) was administered via enteral feeding during the first 7 days. Variables of interest were: Sequential Organ Failure Assessment (SOFA) score evolution, systemic concentrations of lactate, fibrinogen and D-dimer; skin and mucosa colonization and infectious disease register.
Results: Eighty-nine patients were included; 46 in the symbiotic group (SG) and 43 in the control group (CG). There were 68.5% males, with a median age of 69 years. There were no significant differences in the patients' fundamental characteristics (medical history, age, reason for admission, severity scores), nor in the length of ICU stay or in mortality. Comparing the SG with the CG, there were lower lactate levels on the second day, more fibrinogen levels on the days 5 and 7. and lower D-dimer levels on the day 7. Eight hundred and ninety-five cultures were performed for colonization assessment, with isolation of 528 microorganisms. No differences in microbiological resistance were found; there were more colonization in the SG by Candid in mucous membranes after the third day; this situation resolved after stopping symbiotic administration. Twenty-two patients suffered an infectious disease in ICU, 14 in SG (42.4%) and 19 in CG (57.6%). Although no differences were found in the microbiological pattern, there was a predominance of Candida spp. over other microorganisms (4 vs. 0 cases).
Conclusions: The symbiotic preparation Simbiotic Drink (R), administered in MOF, results in differences to improve the early lactate levels and late fibrinogen/D-dimer levels as well as mucosa colonization by Candida. There were no differences in the ICU evolution.

• 出版日期2014-8-19